Overview:
Growing rates of spinal injuries such as degenerative disc disease or deformity have propelled the rise in investments in research activities by industrial players for the treatment and stabilization of the thoracolumbar spine. According to spinalcord.com around 2,45,000 to 3,53,000 Americans were projected to live with spinal cord injuries in 2017. Traditional open surgeries required prolonged hospital stay and are extensively painful. The need for new minimal invasive technology is increasing among healthcare providers and patients. Simplifying spinal surgeries is on a rise thus contributing to the overall growth of thoracolumbar spine devices market.
On December 7 2017, PEEK-OPTIMA HA enhanced vertebral body replacement system was granted US FDA 510(k) clearance. The device enables fine adjustments of heights and lordosis using spacers and endplates. It also comprises of a hollow centre and holes to accommodate auto-graft and encourage growth of new bone. On October 25 2017, Zimmer Biomet Holdings, Inc. launched Vitality+ and Vital Spinal Fixation Systems in United States. Vital Spinal Fixation system offers a compact solution for degenerative thoracolumbar procedures. Advent of such new technologies and continuous research initiatives ensures lucrativeness throughout the period from 2018 to 2026. Implant devices are expected to contribute majorly to the overall market owing to lower side effects, attainment of better quality of life, and highest preference to geriatric population who are prone to spinal diseases. However, highly priced devices and procedures, requirement of skilled healthcare professional and lack of structured reimbursement policies in low and middle-income economies would hamper the geographic expansion of thoracolumbar spinal devices market and negatively affect the overall market growth.
The Global Thoracolumbar Spine Devices Market is segmented as follows:
- By Product Type
- Vertebral Body Replacement System
- MACS TL/MACS II system
- Spinal System
- Spondylolisthesis Reduction Instrumentation (SRI)
- Fracture Reduction Instrumentation (FRI)
- Bone Transforaminal/Aneterior/Posterior Lumbar Interbody Fusion
- Stand Alone Interbody Device (SIBD) Spinal System
- Micro Lumbar Disectomy (MLD) Retractor System
- CASPAR Lumbar Retractor (CLR) System
- Others (Artificial Disc, Retractor System etc.)
- By Geography
- North America
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Rest of Middle East & Africa
Thoracolumbar spinal devices market comprises of a competitive pool with various market leaders enjoying supremacy. Partnerships and acquisitions renders the market to be competitive and challenges the entry of new emerging market players. On September 7 2017, NuVasive, Inc. acquired Vetera Spine. The acquisition reflected NuVasive’s commitment to expand its product portfolio and marks its position as leader in spinal devices. Other key industrial players enjoying dominant position in this market are Aesculap Implant Systems, LLC, B.Braun Melsungen AG, DePuy Synthes, Inc., Globus Medical, Inc., Invibo Ltd., Medtronic plc., Stryker Corp. and Zimmer Biomet Holdings, Inc.
This report offers:
- An overview of the global thoracolumbar spine devices market
- Market trends and extensive analysis for the forecast period from 2018 to 2026; along with historical data for 2016 and considering 2017 as the base year.
- Market evaluation pertaining to each segment
- Qualitative information with respect to market drivers, opportunities and restraints
- A detailed information on the existing thoracolumbar spine devices manufacturers
- A complete understanding on the competitive landscape and profiles of key market players
